# electroCore to Present at the Market Movers Investor Summit on May 5, 2026
Canonical URL: https://biopharmsignal.com/news/ECOR/electrocore-to-present-at-the-market-movers-investor-summit-on-may-5-2026-9c1ced3a
Ticker: ECOR
Company: electroCore
Source: electroCore
Published: 2026-04-28 12:00 EST
## Summary

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company,...

## Article Body
electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be participating in the Market Movers Investor Summit at the historic Bank of New York. Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one meetings throughout the day.

Event Details:

Date: Tuesday, May 5, 2026

Company Presentation: 12:20 PM ET

Location: 48 Wall Street, New York, NY (The original Bank of New York)

Request an invitation to attend at www.marketmoverssummit.com .

Summary of Market Movers Investor Summit The 2026 Market Movers Investor Summit begins on May 4th with a kickoff party at the legendary Delmonico’s, followed by a full day of programming on May 5th. The summit brings together public and private company executives, fund managers, and family offices for a focused, high-caliber experience. The agenda includes company presentations and one-on-one meetings, exclusive fireside chats and keynote sessions, a pop-up lunch from the legendary Katz Delicatessen, and a surprise musical guest.

About electroCore, Inc. electroCore, Inc. is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products, gammaCore ® non-invasive vagus nerve stimulation (nVNS) and Quell ® neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its handheld, and personal use Truvaga™ and TAC-STIM™ nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.

For more information, visit www.electrocore.com .

Contact: ECOR Investor Relations (973) 302-9253 investors@electrocore.com
## Recent Company News
- 2026-07-16 12:00 EST — [New Review Examines Anatomical and Methodological Differences Between Auricular and Cervical Vagus Nerve Stimulation](https://biopharmsignal.com/news/ECOR/new-review-examines-anatomical-and-methodological-differences-between-auricular--75858401) — Source: electroCore
- 2026-06-17 12:00 EST — [electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference](https://biopharmsignal.com/news/ECOR/electrocore-to-participate-in-iaccess-alpha-virtual-best-ideas-summer-investment-07437969) — Source: electroCore
- 2026-06-09 12:00 EST — [Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery](https://biopharmsignal.com/news/ECOR/frontiers-in-neuroscience-accepts-review-article-synthesizing-evidence-that-cerv-90a5568d) — Source: electroCore
- 2026-06-02 12:00 EST — [electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub](https://biopharmsignal.com/news/ECOR/electrocore-to-present-at-the-planet-microcap-las-vegas-2026-powered-by-microcap-9774a6c0) — Source: electroCore
- 2026-05-13 12:00 EST — [electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia](https://biopharmsignal.com/news/ECOR/electrocore-announces-publication-in-jama-highlighting-the-benefits-of-adding-qu-c4813dca) — Source: electroCore
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)